These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15322490)

  • 1. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma.
    Varma V; Cohen C
    Adv Anat Pathol; 2004 Sep; 11(5):239-49. PubMed ID: 15322490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
    Timek DT; Shi J; Liu H; Lin F
    Am J Clin Pathol; 2012 Aug; 138(2):203-10. PubMed ID: 22904131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
    Atta IS
    Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte paraffin-1, CD10, and CD34 immunostaining as a diagnostic aid in cytologic diagnosis of hepatic cancer.
    Agarwal A; Handa U; Kundu R; Sachdev A; Kochhar S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S434-S438. PubMed ID: 36510999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M; Kwok S; Yano H; Pai RK
    Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
    McKnight R; Nassar A; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.
    Yoder M; Zimmerman RL; Bibbo M
    Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
    Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R
    Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin gene expression in liver tumors: diagnostic interest in fine needle aspiration biopsies.
    Papotti M; Pacchioni D; Negro F; Bonino F; Bussolati G
    Mod Pathol; 1994 Apr; 7(3):271-5. PubMed ID: 8058698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
    Wang L; Vuolo M; Suhrland MJ; Schlesinger K
    Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.
    Wee A
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):266-72. PubMed ID: 16932016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.
    Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
    Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
    Gottschalk-Sabag S; Ron N; Glick T
    Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
    Enan ET; El-Hawary AK; El-Tantawy DA; Abu-Hashim MM; Helal NM
    Ann Diagn Pathol; 2013 Dec; 17(6):490-3. PubMed ID: 24012547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers.
    Proca DM; Niemann TH; Porcell AI; DeYoung BR
    Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):120-5. PubMed ID: 10937059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
    Giedl J; Büttner-Herold M; Wach S; Wullich B; Hartmann A; Agaimy A
    Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.